 | • レポートコード：MRC2-11QY10915 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は家庭用乱用薬物検査のグローバル市場について調査・分析したレポートです。種類別（検査カップ、検査ディップカード、検査ストリップ、その他）市場規模、用途別（尿、唾液、髪、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別家庭用乱用薬物検査の競争状況、市場シェア ・世界の家庭用乱用薬物検査市場：種類別市場規模 2015年-2020年（検査カップ、検査ディップカード、検査ストリップ、その他） ・世界の家庭用乱用薬物検査市場：種類別市場規模予測 2021年-2026年（検査カップ、検査ディップカード、検査ストリップ、その他） ・世界の家庭用乱用薬物検査市場：用途別市場規模 2015年-2020年（尿、唾液、髪、その他） ・世界の家庭用乱用薬物検査市場：用途別市場規模予測 2021年-2026年（尿、唾液、髪、その他） ・北米の家庭用乱用薬物検査市場分析：米国、カナダ ・ヨーロッパの家庭用乱用薬物検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの家庭用乱用薬物検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の家庭用乱用薬物検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの家庭用乱用薬物検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：UCP Biosciences、Orient New Life Medical、Express Diagnostics Int’l、Assure Tech (Hangzhou)、Psychemedics Corporation、Confirm BioSciences、Phamatech、Home Health (U.K.) Ltd.、Quest Products ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Market Analysis and Insights: Global At-Home Drug of Abuse (DOA) Testing Market
The global At-Home Drug of Abuse (DOA) Testing market size is projected to reach US$ 426 million by 2026, from US$ 381.5 million in 2020, at a CAGR of 10.6%% during 2021-2026.
Global At-Home Drug of Abuse (DOA) Testing Scope and Market Size
At-Home Drug of Abuse (DOA) Testing market is segmented 4, and 4. Players, stakeholders, and other participants in the global At-Home Drug of Abuse (DOA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast 4 and 4 in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Market segment 4, the product can be split into
Test Cups
Test Dip Cards
Test Strips
Others
Market segment 4, split into
Urine
Saliva
Hair
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
1.4 Market 4
1.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate 4: 2020 VS 2026
1.4.2 Test Cups
1.4.3 Test Dip Cards
1.4.4 Test Strips
1.4.5 Others
1.5 Market by Application
1.5.1 Global At-Home Drug of Abuse (DOA) Testing Market Share 4: 2020 VS 2026
1.5.2 Urine
1.5.3 Saliva
1.5.4 Hair
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2015-2026)
2.2 Global At-Home Drug of Abuse (DOA) Testing Growth Trends by Regions
2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Share by Regions (2015-2020)
2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 At-Home Drug of Abuse (DOA) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key At-Home Drug of Abuse (DOA) Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Market Size
3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2015-2020)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
3.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2019
3.3 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.4 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
3.5 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size 4 (2015-2026)
4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size 4 (2015-2020)
4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size 4 (2021-2026)
5 Market Size 4 (2015-2026)
5.1 Global At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size 4 (2021-2026)
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
6.2 At-Home Drug of Abuse (DOA) Testing Key Players in North America (2019-2020)
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
7.2 At-Home Drug of Abuse (DOA) Testing Key Players in Europe (2019-2020)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
8 China
8.1 China At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
8.2 At-Home Drug of Abuse (DOA) Testing Key Players in China (2019-2020)
8.3 China At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
8.4 China At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
9 Japan
9.1 Japan At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
9.2 At-Home Drug of Abuse (DOA) Testing Key Players in Japan (2019-2020)
9.3 Japan At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
9.4 Japan At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020)
10 Southeast Asia
10.1 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
10.2 At-Home Drug of Abuse (DOA) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)
11 India
11.1 India At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
11.2 At-Home Drug of Abuse (DOA) Testing Key Players in India (2019-2020)
11.3 India At-Home Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
11.4 India At-Home Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America At-Home Drug of Abuse (DOA) Testing Market Size (2015-2020)
12.2 At-Home Drug of Abuse (DOA) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
12.4 Central & South America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 UCP Biosciences
13.1.1 UCP Biosciences Company Details
13.1.2 UCP Biosciences Business Overview
13.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
13.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020))
13.1.5 UCP Biosciences Recent Development
13.2 Orient New Life Medical
13.2.1 Orient New Life Medical Company Details
13.2.2 Orient New Life Medical Business Overview
13.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
13.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.2.5 Orient New Life Medical Recent Development
13.3 Express Diagnostics Int’l
13.3.1 Express Diagnostics Int’l Company Details
13.3.2 Express Diagnostics Int’l Business Overview
13.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
13.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.3.5 Express Diagnostics Int’l Recent Development
13.4 Assure Tech (Hangzhou)
13.4.1 Assure Tech (Hangzhou) Company Details
13.4.2 Assure Tech (Hangzhou) Business Overview
13.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
13.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.4.5 Assure Tech (Hangzhou) Recent Development
13.5 Psychemedics Corporation
13.5.1 Psychemedics Corporation Company Details
13.5.2 Psychemedics Corporation Business Overview
13.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
13.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.5.5 Psychemedics Corporation Recent Development
13.6 Confirm BioSciences
13.6.1 Confirm BioSciences Company Details
13.6.2 Confirm BioSciences Business Overview
13.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
13.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.6.5 Confirm BioSciences Recent Development
13.7 Phamatech
13.7.1 Phamatech Company Details
13.7.2 Phamatech Business Overview
13.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
13.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.7.5 Phamatech Recent Development
13.8 Home Health (U.K.) Ltd.
13.8.1 Home Health (U.K.) Ltd. Company Details
13.8.2 Home Health (U.K.) Ltd. Business Overview
13.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
13.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.8.5 Home Health (U.K.) Ltd. Recent Development
13.9 Quest Products
13.9.1 Quest Products Company Details
13.9.2 Quest Products Business Overview
13.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
13.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020)
13.9.5 Quest Products Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. At-Home Drug of Abuse (DOA) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
Table 3. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate 4 (US$ Million): 2020 VS 2026
Table 5. Key Players of Test Cups
Table 6. Key Players of Test Dip Cards
Table 7. Key Players of Test Strips
Table 8. Key Players of Others
Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth 4 (US$ Million): 2020 VS 2026
Table 10. Global At-Home Drug of Abuse (DOA) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2015-2020)
Table 13. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. At-Home Drug of Abuse (DOA) Testing Market Growth Strategy
Table 19. Main Points Interviewed from Key At-Home Drug of Abuse (DOA) Testing Players
Table 20. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2015-2020) (Million US$)
Table 21. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players (2015-2020)
Table 22. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2019)
Table 23. Global At-Home Drug of Abuse (DOA) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
Table 26. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size Share 4 (2015-2020)
Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share 4 (2021-2026)
Table 31. Global At-Home Drug of Abuse (DOA) Testing Market Size Share 4 (2015-2020)
Table 32. Global At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 33. Global At-Home Drug of Abuse (DOA) Testing Market Size Share 4 (2021-2026)
Table 34. North America Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 35. North America Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 36. North America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 37. North America At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 38. North America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 39. North America At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 40. Europe Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 42. Europe At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 43. Europe At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 44. Europe At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 45. Europe At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 46. China Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 47. China Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 48. China At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 49. China At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 50. China At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 51. China At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 52. Japan Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 54. Japan At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 55. Japan At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 56. Japan At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 57. Japan At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 58. Southeast Asia Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 60. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 61. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 62. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 63. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 64. India Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 65. India Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 66. India At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 67. India At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 68. India At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 69. India At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 70. Central & South America Key Players At-Home Drug of Abuse (DOA) Testing Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players At-Home Drug of Abuse (DOA) Testing Market Share (2019-2020)
Table 72. Central & South America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 73. Central & South America At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 74. Central & South America At-Home Drug of Abuse (DOA) Testing Market Size 4 (2015-2020) (Million US$)
Table 75. Central & South America At-Home Drug of Abuse (DOA) Testing Market Share 4 (2015-2020)
Table 76. UCP Biosciences Company Details
Table 77. UCP Biosciences Business Overview
Table 78. UCP Biosciences Product
Table 79. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 80. UCP Biosciences Recent Development
Table 81. Orient New Life Medical Company Details
Table 82. Orient New Life Medical Business Overview
Table 83. Orient New Life Medical Product
Table 84. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 85. Orient New Life Medical Recent Development
Table 86. Express Diagnostics Int’l Company Details
Table 87. Express Diagnostics Int’l Business Overview
Table 88. Express Diagnostics Int’l Product
Table 89. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 90. Express Diagnostics Int’l Recent Development
Table 91. Assure Tech (Hangzhou) Company Details
Table 92. Assure Tech (Hangzhou) Business Overview
Table 93. Assure Tech (Hangzhou) Product
Table 94. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 95. Assure Tech (Hangzhou) Recent Development
Table 96. Psychemedics Corporation Company Details
Table 97. Psychemedics Corporation Business Overview
Table 98. Psychemedics Corporation Product
Table 99. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 100. Psychemedics Corporation Recent Development
Table 101. Confirm BioSciences Company Details
Table 102. Confirm BioSciences Business Overview
Table 103. Confirm BioSciences Product
Table 104. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 105. Confirm BioSciences Recent Development
Table 106. Phamatech Company Details
Table 107. Phamatech Business Overview
Table 108. Phamatech Product
Table 109. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 110. Phamatech Recent Development
Table 111. Home Health (U.K.) Ltd. Business Overview
Table 112. Home Health (U.K.) Ltd. Product
Table 113. Home Health (U.K.) Ltd. Company Details
Table 114. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 115. Home Health (U.K.) Ltd. Recent Development
Table 116. Quest Products Company Details
Table 117. Quest Products Business Overview
Table 118. Quest Products Product
Table 119. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2015-2020) (Million US$)
Table 120. Quest Products Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Share 4: 2020 VS 2026
Figure 2. Test Cups Features
Figure 3. Test Dip Cards Features
Figure 4. Test Strips Features
Figure 5. Others Features
Figure 6. Global At-Home Drug of Abuse (DOA) Testing Market Share 4: 2020 VS 2026
Figure 7. Urine Case Studies
Figure 8. Saliva Case Studies
Figure 9. Hair Case Studies
Figure 10. Others Case Studies
Figure 11. At-Home Drug of Abuse (DOA) Testing Report Years Considered
Figure 12. Global At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2019
Figure 17. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2019
Figure 19. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…- 乱用薬物検査の世界市場（～2026年） Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, …
- アルコール中毒モニタリングの世界市場（～2026年） Alcohol abuse is a severe problem and addiction that affects people at all age groups. Alcohol abuse has reported many serious cases and injuries in the recent past. Moreover, alcohol abuse also plays a role in many major social problems, such as drunk driving, violence, stress, and child abuse etc.…
- 薬物乱用治療の世界市場（～2026年） Substance abuse has become a major cause of concern. People are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes …
- ポイントオブケア検査の世界市場（～2026年） Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-…